Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 109 entries
Sorted by: Best Match Show Resources per page
Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design.

Diabetes, metabolic syndrome and obesity : targets and therapy

Strack T, Martinez L, Del Prato S, Blonde L, Göke B, Woo V, Millward A, Gomis R, Canovatchel B, Lawrence D, Freemantle N.
PMID: 21437114
Diabetes Metab Syndr Obes. 2009 Jan 20;2:1-10.

OBJECTIVE: The purpose of the trial was to examine the impact of inhaled human insulin (INH) on patient or physician willingness to adopt insulin after oral diabetes agent failure.RESEARCH DESIGN AND METHODS: The EXPERIENCE trial was a one-year randomized...

Cite
Strack T, Martinez L, Del Prato S, et al. Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design. Diabetes Metab Syndr Obes. 2009;2:1-10
Strack, T., Martinez, L., Del Prato, S., Blonde, L., Göke, B., Woo, V., Millward, A., Gomis, R., Canovatchel, B., Lawrence, D., & Freemantle, N. (2009). Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design. Diabetes, metabolic syndrome and obesity : targets and therapy, 21-10.
Strack, Thomas, et al. "Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 2 (2009): 1-10.
Strack T, Martinez L, Del Prato S, Blonde L, Göke B, Woo V, Millward A, Gomis R, Canovatchel B, Lawrence D, Freemantle N. Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design. Diabetes Metab Syndr Obes. 2009 Jan 20;2:1-10. PMID: 21437114; PMCID: PMC3048012.
Copy Download .nbib Format: NLM
Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Lionel KR, John J, Sen N.
PMID: 24550609
Indian J Crit Care Med. 2014 Jan;18(1):21-5. doi: 10.4103/0972-5229.125431.

BACKGROUND AND AIM: Although large studies have demonstrated the association between hyperglycemia and adverse intensive care unit (ICU) outcomes, it is yet unclear which subset of patients benefit from tight sugar control in ICU. Recent evidence suggests that stress...

Cite
Lionel KR, John J, Sen N. Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit. Indian J Crit Care Med. 2014;18(1):21-5doi: 10.4103/0972-5229.125431.
Lionel, K. R., John, J., & Sen, N. (2014). Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 18(1), 21-5. https://doi.org/10.4103/0972-5229.125431
Lionel, Karen Ruby, et al. "Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 18,1 (2014): 21-5. doi: https://doi.org/10.4103/0972-5229.125431
Lionel KR, John J, Sen N. Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit. Indian J Crit Care Med. 2014 Jan;18(1):21-5. doi: 10.4103/0972-5229.125431. PMID: 24550609; PMCID: PMC3912663.
Copy Download .nbib Format: NLM
Enhanced glycemic control with combination therapy for type 2 diabetes in primary care.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Kuritzky L, Samraj GP.
PMID: 22127825
Diabetes Ther. 2011 Sep;2(3):162-77. doi: 10.1007/s13300-011-0006-z. Epub 2011 Aug 01.

Type 2 diabetes mellitus is an increasingly common medical problem for primary care clinicians to address. Treatment of diabetes has evolved from simple replacement of insulin (directly or through insulin secretagogs) through capture of mechanisms such as insulin sensitizers,...

Cite
Kuritzky L, Samraj GP. Enhanced glycemic control with combination therapy for type 2 diabetes in primary care. Diabetes Ther. 2011;2(3):162-77doi: 10.1007/s13300-011-0006-z.
Kuritzky, L., & Samraj, G. P. (2011). Enhanced glycemic control with combination therapy for type 2 diabetes in primary care. Diabetes therapy : research, treatment and education of diabetes and related disorders, 2(3), 162-77. https://doi.org/10.1007/s13300-011-0006-z
Kuritzky, Louis, and Samraj, George P. "Enhanced glycemic control with combination therapy for type 2 diabetes in primary care." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 2,3 (2011): 162-77. doi: https://doi.org/10.1007/s13300-011-0006-z
Kuritzky L, Samraj GP. Enhanced glycemic control with combination therapy for type 2 diabetes in primary care. Diabetes Ther. 2011 Sep;2(3):162-77. doi: 10.1007/s13300-011-0006-z. Epub 2011 Aug 01. PMID: 22127825; PMCID: PMC3173597.
Copy Download .nbib Format: NLM
Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease.

Diabetes & metabolism journal

Huh JH, Lee M, Park SY, Kim JH, Lee BW.
PMID: 29885104
Diabetes Metab J. 2018 Jun;42(3):215-223. doi: 10.4093/dmj.2017.0091. Epub 2018 May 02.

BACKGROUND: The aim of this study was to investigate which glycemic parameters better reflect urinary N-acetyl-β-D-glucosaminidase (uNAG) abnormality, a marker for renal tubulopathy, in subjects with type 2 diabetes mellitus (T2DM) subjects with normoalbuminuria and a normal estimated glomerular...

Cite
Huh JH, Lee M, Park SY, et al. Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease. Diabetes Metab J. 2018;42(3):215-223doi: 10.4093/dmj.2017.0091.
Huh, J. H., Lee, M., Park, S. Y., Kim, J. H., & Lee, B. W. (2018). Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease. Diabetes & metabolism journal, 42(3), 215-223. https://doi.org/10.4093/dmj.2017.0091
Huh, Ji Hye, et al. "Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease." Diabetes & metabolism journal vol. 42,3 (2018): 215-223. doi: https://doi.org/10.4093/dmj.2017.0091
Huh JH, Lee M, Park SY, Kim JH, Lee BW. Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease. Diabetes Metab J. 2018 Jun;42(3):215-223. doi: 10.4093/dmj.2017.0091. Epub 2018 May 02. PMID: 29885104; PMCID: PMC6015965.
Copy Download .nbib Format: NLM
Association between White Blood Cell Counts within Normal Range and Hemoglobin A1c in a Korean Population.

Endocrinology and metabolism (Seoul, Korea)

Hong JW, Noh JH, Kim DJ.
PMID: 29388402
Endocrinol Metab (Seoul). 2018 Mar;33(1):79-87. doi: 10.3803/EnM.2018.33.1.79. Epub 2018 Jan 30.

BACKGROUND: We examined whether white blood cell (WBC) count levels within normal range, could be associated with hemoglobin A1c (HbA1c) levels.METHODS: Among the 11,472 people (≥19 years of age) who participated in the 2011 to 2012 Korea National Health...

Cite
Hong JW, Noh JH, Kim DJ. Association between White Blood Cell Counts within Normal Range and Hemoglobin A1c in a Korean Population. Endocrinol Metab (Seoul). 2018;33(1):79-87doi: 10.3803/EnM.2018.33.1.79.
Hong, J. W., Noh, J. H., & Kim, D. J. (2018). Association between White Blood Cell Counts within Normal Range and Hemoglobin A1c in a Korean Population. Endocrinology and metabolism (Seoul, Korea), 33(1), 79-87. https://doi.org/10.3803/EnM.2018.33.1.79
Hong, Jae Won, et al. "Association between White Blood Cell Counts within Normal Range and Hemoglobin A1c in a Korean Population." Endocrinology and metabolism (Seoul, Korea) vol. 33,1 (2018): 79-87. doi: https://doi.org/10.3803/EnM.2018.33.1.79
Hong JW, Noh JH, Kim DJ. Association between White Blood Cell Counts within Normal Range and Hemoglobin A1c in a Korean Population. Endocrinol Metab (Seoul). 2018 Mar;33(1):79-87. doi: 10.3803/EnM.2018.33.1.79. Epub 2018 Jan 30. PMID: 29388402; PMCID: PMC5874199.
Copy Download .nbib Format: NLM
One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-Care.

JMIR mHealth and uHealth

Osborn CY, van Ginkel JR, Marrero DG, Rodbard D, Huddleston B, Dachis J.
PMID: 29187344
JMIR Mhealth Uhealth. 2017 Nov 29;5(11):e179. doi: 10.2196/mhealth.8781.

BACKGROUND: The One Drop | Mobile app supports manual and passive (via HealthKit and One Drop's glucose meter) tracking of self-care and glycated hemoglobin AOBJECTIVE: We assessed the HbAMETHODS: In June 2017, we identified people with diabetes using the...

Cite
Osborn CY, van Ginkel JR, Marrero DG, et al. One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-Care. JMIR Mhealth Uhealth. 2017;5(11):e179doi: 10.2196/mhealth.8781.
Osborn, C. Y., van Ginkel, J. R., Marrero, D. G., Rodbard, D., Huddleston, B., & Dachis, J. (2017). One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-Care. JMIR mHealth and uHealth, 5(11), e179. https://doi.org/10.2196/mhealth.8781
Osborn, Chandra Y, et al. "One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-Care." JMIR mHealth and uHealth vol. 5,11 (2017): e179. doi: https://doi.org/10.2196/mhealth.8781
Osborn CY, van Ginkel JR, Marrero DG, Rodbard D, Huddleston B, Dachis J. One Drop | Mobile on iPhone and Apple Watch: An Evaluation of HbA1c Improvement Associated With Tracking Self-Care. JMIR Mhealth Uhealth. 2017 Nov 29;5(11):e179. doi: 10.2196/mhealth.8781. PMID: 29187344; PMCID: PMC5729227.
Copy Download .nbib Format: NLM
Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes.

Oman medical journal

Kumah E, Abuosi AA, Ankomah SE, Anaba C.
PMID: 33585046
Oman Med J. 2021 Jan 31;36(1):e225. doi: 10.5001/omj.2021.01. eCollection 2021 Jan.

OBJECTIVES: Self-management education (SME) is recognized globally as a tool that enables patients to achieve optimal glucose control. While factors influencing the effectiveness of self-management interventions have been studied extensively, the impact of program length on clinical endpoints of...

Cite
Kumah E, Abuosi AA, Ankomah SE, et al. Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes. Oman Med J. 2021;36(1):e225doi: 10.5001/omj.2021.01.
Kumah, E., Abuosi, A. A., Ankomah, S. E., & Anaba, C. (2021). Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes. Oman medical journal, 36(1), e225. https://doi.org/10.5001/omj.2021.01
Kumah, Emmanuel, et al. "Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes." Oman medical journal vol. 36,1 (2021): e225. doi: https://doi.org/10.5001/omj.2021.01
Kumah E, Abuosi AA, Ankomah SE, Anaba C. Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes. Oman Med J. 2021 Jan 31;36(1):e225. doi: 10.5001/omj.2021.01. eCollection 2021 Jan. PMID: 33585046; PMCID: PMC7868594.
Copy Download .nbib Format: NLM
Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis.

Advances in therapy

Nishimura R, Taniguchi M, Takeshima T, Iwasaki K.
PMID: 34846709
Adv Ther. 2021 Nov 30; doi: 10.1007/s12325-021-01979-1. Epub 2021 Nov 30.

INTRODUCTION: Although metformin is recommended as a first-line treatment for patients with type 2 diabetes (T2D) in Western countries, no specific treatment is recommended in Japan, and various agents are used. Metformin has long been used at low doses...

Cite
Nishimura R, Taniguchi M, Takeshima T, et al. Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis. Adv Ther. 2021;doi: 10.1007/s12325-021-01979-1.
Nishimura, R., Taniguchi, M., Takeshima, T., & Iwasaki, K. (2021). Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis. Advances in therapy, . https://doi.org/10.1007/s12325-021-01979-1
Nishimura, Rimei, et al. "Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis." Advances in therapy vol. (2021). doi: https://doi.org/10.1007/s12325-021-01979-1
Nishimura R, Taniguchi M, Takeshima T, Iwasaki K. Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis. Adv Ther. 2021 Nov 30; doi: 10.1007/s12325-021-01979-1. Epub 2021 Nov 30. PMID: 34846709.
Copy Download .nbib Format: NLM
Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c.

Journal of diabetes and metabolic disorders

Batalha APDB, Ponciano IC, Chaves G, Felício DC, Britto RR, da Silva LP.
PMID: 34900827
J Diabetes Metab Disord. 2021 Jul 15;20(2):1815-1836. doi: 10.1007/s40200-021-00846-8. eCollection 2021 Dec.

PURPOSE: This study aimed to identify the characteristics of interventions employed to promote behavior change in people with type 2 diabetes mellitus (T2DM) and their impact on disease self-management and glycated hemoglobin (A1c).METHODS: The Preferred Reporting Items for Systematic...

Cite
Batalha APDB, Ponciano IC, Chaves G, et al. Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c. J Diabetes Metab Disord. 2021;20(2):1815-1836doi: 10.1007/s40200-021-00846-8.
Batalha, A. P. D. B., Ponciano, I. C., Chaves, G., Felício, D. C., Britto, R. R., & da Silva, L. P. (2021). Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c. Journal of diabetes and metabolic disorders, 20(2), 1815-1836. https://doi.org/10.1007/s40200-021-00846-8
Batalha, Ana Paula Delgado Bomtempo, et al. "Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c." Journal of diabetes and metabolic disorders vol. 20,2 (2021): 1815-1836. doi: https://doi.org/10.1007/s40200-021-00846-8
Batalha APDB, Ponciano IC, Chaves G, Felício DC, Britto RR, da Silva LP. Behavior change interventions in patients with type 2 diabetes: a systematic review of the effects on self-management and A1c. J Diabetes Metab Disord. 2021 Jul 15;20(2):1815-1836. doi: 10.1007/s40200-021-00846-8. eCollection 2021 Dec. PMID: 34900827; PMCID: PMC8630317.
Copy Download .nbib Format: NLM
Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross-sectional study.

Journal of diabetes and metabolic disorders

Niroomand M, Babaniamansour S, Aliniagerdroudbari E, Golshaian A, Meibodi AM, Absalan A.
PMID: 34178826
J Diabetes Metab Disord. 2021 Jan 18;20(1):141-151. doi: 10.1007/s40200-020-00721-y. eCollection 2021 Jun.

PURPOSE: This study aimed to validate the internal consistency of the Persian version of the diabetes distress scale-17 (DDS-17) and to investigate the prevalence of diabetes distress (DD), depression, and possible relevant factors.METHODS: This was a cross-sectional study on...

Cite
Niroomand M, Babaniamansour S, Aliniagerdroudbari E, et al. Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross-sectional study. J Diabetes Metab Disord. 2021;20(1):141-151doi: 10.1007/s40200-020-00721-y.
Niroomand, M., Babaniamansour, S., Aliniagerdroudbari, E., Golshaian, A., Meibodi, A. M., & Absalan, A. (2021). Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross-sectional study. Journal of diabetes and metabolic disorders, 20(1), 141-151. https://doi.org/10.1007/s40200-020-00721-y
Niroomand, Mahtab, et al. "Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross-sectional study." Journal of diabetes and metabolic disorders vol. 20,1 (2021): 141-151. doi: https://doi.org/10.1007/s40200-020-00721-y
Niroomand M, Babaniamansour S, Aliniagerdroudbari E, Golshaian A, Meibodi AM, Absalan A. Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross-sectional study. J Diabetes Metab Disord. 2021 Jan 18;20(1):141-151. doi: 10.1007/s40200-020-00721-y. eCollection 2021 Jun. PMID: 34178826; PMCID: PMC8212327.
Copy Download .nbib Format: NLM
Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes.

BMJ open diabetes research & care

Cox DJ, Oser T, Moncrief M, Conaway M, McCall A.
PMID: 34845062
BMJ Open Diabetes Res Care. 2021 Nov;9(2). doi: 10.1136/bmjdrc-2021-002403.

INTRODUCTION: We previously reported the physical, psychological and behavioral 3-month post-treatment results of a randomized controlled trial comparing glycemic excursion minimization (GEM) versus conventional weight loss (WL) therapy in the management of type 2 diabetes (T2D). GEM is a...

Cite
Cox DJ, Oser T, Moncrief M, et al. Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes. BMJ Open Diabetes Res Care. 2021;9(2)doi: 10.1136/bmjdrc-2021-002403.
Cox, D. J., Oser, T., Moncrief, M., Conaway, M., & McCall, A. (2021). Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes. BMJ open diabetes research & care, 9(2), . https://doi.org/10.1136/bmjdrc-2021-002403
Cox, Daniel J, et al. "Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes." BMJ open diabetes research & care vol. 9,2 (2021). doi: https://doi.org/10.1136/bmjdrc-2021-002403
Cox DJ, Oser T, Moncrief M, Conaway M, McCall A. Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes. BMJ Open Diabetes Res Care. 2021 Nov;9(2). doi: 10.1136/bmjdrc-2021-002403. PMID: 34845062; PMCID: PMC8634632.
Copy Download .nbib Format: NLM
Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Nagai Y, Kazumori K, Takeshima T, Iwasaki K, Tanaka Y.
PMID: 33598855
Diabetes Ther. 2021 Mar;12(3):897-911. doi: 10.1007/s13300-021-01017-x. Epub 2021 Feb 17.

INTRODUCTION: Metformin has dose-dependent hypoglycemic effects on patients with type 2 diabetes (T2D). In Japan, metformin has been prescribed at lower doses than in Western countries. We analyzed the effect of increasing the metformin dose on glycemic control and...

Cite
Nagai Y, Kazumori K, Takeshima T, et al. Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Diabetes Ther. 2021;12(3):897-911doi: 10.1007/s13300-021-01017-x.
Nagai, Y., Kazumori, K., Takeshima, T., Iwasaki, K., & Tanaka, Y. (2021). Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders, 12(3), 897-911. https://doi.org/10.1007/s13300-021-01017-x
Nagai, Yoshio, et al. "Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 12,3 (2021): 897-911. doi: https://doi.org/10.1007/s13300-021-01017-x
Nagai Y, Kazumori K, Takeshima T, Iwasaki K, Tanaka Y. Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes. Diabetes Ther. 2021 Mar;12(3):897-911. doi: 10.1007/s13300-021-01017-x. Epub 2021 Feb 17. PMID: 33598855; PMCID: PMC7947126.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 109 entries